Login / Signup

Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma.

David G CoffeyQian V WuAndrea M H TowlertonSharon OrnelasAlicia J MoralesYuexin XuDamian J GreenEdus H Warren
Published in: Blood cancer journal (2019)
Keyphrases
  • bone marrow
  • multiple myeloma
  • mesenchymal stem cells
  • single cell
  • cancer therapy